The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
Carboxamide GABAa ALPHA2 Modulators
申请人:Mattson Ronald J.
公开号:US20090093466A1
公开(公告)日:2009-04-09
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.